Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Receivables - Net (2012 - 2026)

Kamada's (KMDA) quarterly Receivables - Net came in at $36.7 million in Q2 2026, up 20.35% on a YoY basis from $30.5 million in Q2 2025, and up 0.53% quarter-over-quarter from $36.5 million in Q1 2026.

Analysis

Kamada (KMDA) Receivables - Net (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Receivables - Net for 15 consecutive years, with $36.7 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Receivables - Net rose 20.35% year-over-year to $36.7 million; the trailing twelve-month figure through Jun 2026 stood at $36.7 million (up 20.35% YoY), and the FY2025 full-year result was $27.0 million, up 25.34% from the prior year.
  • Receivables - Net improved to $36.7 million in Q2 2026 per KMDA's latest filing, from $36.5 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $36.7 million in Q2 2026 and bottomed at $16.3 million in Q3 2024.
  • Historically, Receivables - Net has averaged $25.2 million across 5 years, with a median of $24.8 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Receivables - Net tumbled 36.06% in 2022, then soared 92.57% in 2025.
  • Over 5 years, Receivables - Net stood at $27.3 million in 2022, then slipped by 27.06% to $19.9 million in 2023, then grew by 8.4% to $21.5 million in 2024, then climbed by 25.34% to $27.0 million in 2025, then surged by 35.92% to $36.7 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $36.7 million, $36.5 million, and $27.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.39 Bn 197.40 Bn 7.24 Bn
2 Gilead Sciences 181.14 Bn 177.96 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.24 Bn 124.39 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.91 Bn 74.91 Bn 3.93 Bn
5 Argenx Se 61.55 Bn 56.36 Bn 1.37 Bn
6 Moderna 54.39 Bn 49.25 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.43 Bn 31.12 Bn 992.69 Mn
8 Biogen 31.18 Bn 29.89 Bn 1.96 Bn
9 Roivant Sciences 30.11 Bn 30.11 Bn 1.16 Mn
10 Kamada 472.70 Mn 402.57 Mn 22.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.71 Mn
Mar 31, 2026 36.52 Mn
Dec 31, 2025 27.01 Mn
Sep 30, 2025 31.38 Mn
Jun 30, 2025 30.50 Mn
Mar 31, 2025 27.88 Mn
Dec 31, 2024 21.55 Mn
Sep 30, 2024 16.30 Mn
Jun 30, 2024 26.23 Mn
Mar 31, 2024 18.86 Mn
Dec 31, 2023 19.88 Mn
Sep 30, 2023 25.11 Mn
Jun 30, 2023 24.58 Mn
Mar 31, 2023 20.93 Mn
Dec 31, 2022 27.25 Mn
Sep 30, 2022 24.00 Mn
Jun 30, 2022 17.74 Mn
Mar 31, 2022 21.57 Mn
Dec 31, 2021 35.16 Mn
Sep 30, 2021 26.55 Mn